Back
Direxion Daily S&P Biotech Bear 3X Shares Vs. Akero Therapeutics Industry Stock Comparison
Sell
27
LABD
Direxion Daily S&P Biotech Bear 3X Shares
Last Price:
$5.95
Seasonality Move:
13.52%
Sell
33
AKRO
Akero Therapeutics
Last Price:
$47.65
Seasonality Move:
26.87%
Sell
27
Direxion Daily S&P Biotech Bear 3X Shares (LABD)
is a Sell
Is Direxion Daily S&P Biotech Bear 3X Shares a Buy, Sell or Hold?
-
The current Direxion Daily S&P Biotech Bear 3X Shares [LABD] share price is $5.60. The Score for LABD is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
-
LABD is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
33
Akero Therapeutics (AKRO)
is a Sell
Is Akero Therapeutics a Buy, Sell or Hold?
-
The current Akero Therapeutics [AKRO] share price is $48.59. The Score for AKRO is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
-
AKRO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
LABD Stock Price Chart
What is Direxion Daily S&P Biotech Bear 3X Shares's stock price today?
-
The Direxion Daily S&P Biotech Bear 3X Shares share price today is $5.60The current trend is moderately bullish and LABD is experiencing buying pressure, which is a positive indicator for future bullish movement.
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $48.59Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AKRO is experiencing selling pressure, which indicates risk of future bearish movement.
LABD Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.45 | Buy |
Relative Strength Index (14 RSI): | 33.18 | Sell |
Chaikin Money Flow: | -13512508 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
AKRO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.61 | Sell |
Relative Strength Index (14 RSI): | 44.71 | Sell |
Chaikin Money Flow: | -397216 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (48.31 - 52.03) | Sell |
Bollinger Bands (100): | (40.91 - 53.21) | Buy |
LABD Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 6.31 | Sell |
20-day SMA: | 6.39 | Sell |
50-day SMA: | 6.78 | Sell |
200-day SMA: | 7.38 | Sell |
8-day EMA: | 5.94 | Sell |
20-day EMA: | 4.75 | Buy |
50-day EMA: | 2.73 | Buy |
200-day EMA: | 0.84 | Buy |
AKRO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 49.2 | Sell |
20-day SMA: | 49.55 | Sell |
50-day SMA: | 51.86 | Sell |
200-day SMA: | 42 | Buy |
8-day EMA: | 49.19 | Sell |
20-day EMA: | 49.76 | Sell |
50-day EMA: | 49.88 | Sell |
200-day EMA: | 43.09 | Buy |
Direxion Daily S&P Biotech Bear 3X Shares Earnings Growth & LABD Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.13 per share, an increase this year of $0.23 per share, and a decrease next year of $0.61 per share.
Direxion Daily S&P Biotech Bear 3X Shares Technical Analysis
Aug 5 | Aug 6 | Aug 7 | Aug 8 | Aug 11 | Aug 12 | Aug 13 | Aug 14 | Aug 15 | Aug 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Aug | ||||||||||
05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Akero Therapeutics Technical Analysis
Aug 5 | Aug 6 | Aug 7 | Aug 8 | Aug 11 | Aug 12 | Aug 13 | Aug 14 | Aug 15 | Aug 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Aug | ||||||||||
05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |